Abstract
Background:Tapering of tumor necrosis factor inhibitor (TNFi) treatment in patients who have reached sustained remission is debated in current guidelines, and further data are needed regarding the long-term consequences of...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have